Reports and Data

Veterinary Artificial Insemination Market Trends, Revenue, Key Players, Growth, Share and Forecast Till 2027

The rising venereal diseases in animals and growing awareness among humans about artificial insemination is driving the demand for the market.

 

New York, NY -- (SBWIRE) -- 05/03/2021 -- Veterinary Artificial Insemination Market Size – USD 3.82 billion in 2019, Industry Growth - CAGR of 5.8%, Industry Trends – Increased Animal Husbandry.

The Global Veterinary Artificial Insemination market is anticipated to reach USD 5.94 billion by 2027, according to a new report by Reports and Data. The Artificial Insemination Market (AI) is expected to see a rise in demand due to increased animal protein consumption and increased demand for high cattle productivity & milk yields. Market players are introducing artificial insemination to meet the ever-increasing demand to breed high-quality livestock and increase efficiency. Demand has increased over the years, owing to the growing prevalence of various animal diseases, such as zoonotic diseases, and the increasing adoption of animals that follow them.

According to the 2019 publication of the Food and Agriculture Organization (FAO), livestock accounted for approximately 40 % of the global value of agricultural production in developed countries and 20% in developing countries, providing food security and livelihood for more than 1.3 billion people worldwide. Favorable government regulations aimed at increasing productivity often contribute to growth; for example, in 2018 the Indian government authorized an Agriculture Export Policy to boost the nation's agricultural economic growth. The new strategy aims to raise India's agricultural production to USD 60 billion by 2022 and USD 100 billion in the next few years with a stable foreign-policy system.

The industry meets the guidelines set by the International Artificial Insemination Society (ISAG) and leading laboratories for animal science, such as Davis University of California (U.C. Davis). The standard ISAG panel consists of 18 STR markers, and every artificial insemination business needs to adopt the panel and norm set by the authority. Nevertheless, increasing populations are expected to pose a continuous challenge to food supply and animal protein requirement, boosting demand development.

Request a Sample Copy of the Research Report @ https://www.reportsanddata.com/sample-enquiry-form/3476

The Key Companies Profiled in the Market are:

Select Sires, Inc., Swine Genetics International, SEMEX, Zoetis, Cooperative Resource International (GENEX), Cogent, Viking Genetics, Genus plc, Polar Genetics India, and Fox Fire Farm, among others.

COVID-19 Impact:

It is expected that the COVID-19 pandemic would affect corporate growth. In the aftermath of the COVID 19 pandemic, large companies have announced output suspension as a result of reduced demand and supply chains and their workers being safeguarded. Demand for solutions is expected to go down by 2020. Farmers can adjust demand so they can prevent bottlenecks. Tier 1 players agree that progress is unlikely to restart in the near future due to the serious pandemic in the remaining quarter of 2020, in particular in the United States and major European countries.

Further key findings from the report suggest

Given the rising consumption of milk and its products in Asian countries, the cattle segment was the largest revenue-generating segment in 2019.

The usual semen segment represented the largest share of revenue in the drug category in 2019, due to the low cost of the procedure.

The animal husbandry accounts for the largest share in the end-user segment and is expected to retain its predominance over the forecast period. The increase can be attributed to the maximum number of procedures for collecting semen conducted under such facilities.

Use of sexed semen is expected to display the highest growth over the forecast period.

Asia Pacific was the region's leading sector and accounts for the largest share of revenue in 2019 mainly due to the region's high cattle population.

In May 2019, Genus plc partnered with the China based Beijing Capital Agribusiness (BCA). BCA is intended to help the organization grow reproductive and respiratory syndrome virus (PrRVS)–resistant animals in proprietary technology applications.

Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/3476

For the purpose of this study, Reports and Data have segmented the Veterinary Artificial Insemination market on the basis of Product, Therapeutic Application, End-Use, and region:

Product Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

Normal Semen
Sexed Semen

Animal Type Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

Cattle
Swine
Sheep
Canine
Equine
Others

End-Use Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

Veterinary Hospitals
Animal Husbandry
Others

Regional Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

North America
U.S
Canada
Europe
U.K
Germany
France
BENELUX
Asia Pacific
China
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
MEA
Saudi Arabia
UAE
Rest of MEA

Request for Customization @ https://www.reportsanddata.com/request-customization-form/3476

Table of contents           

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Indicative Metrics

Chapter 4. Veterinary Artificial Insemination Market Segmentation & Impact Analysis

    4.1. Veterinary Artificial Insemination Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Reducing cost of maintaining a bull

                    4.2.2.2. Increased Efficiency

                    4.2.2.3. Improving animals' Productivity

                    4.2.2.4. Increasing consumer awareness about benefits of animal protein

          4.2.3. Market restraints analysis

                    4.2.3.1. Negative Impact OF artificial insemination In Genetic Diversity

                    4.2.3.2. Stringent Regulatory policies

4.3. Technological Insights

4.4. Regulatory Framework

4.5. ETOP Analysis

4.6. Porter's Five Forces Analysis

4.7. Competitive Metric Space Analysis

4.8. Price trend Analysis

4.9. Customer Mapping

4.10. Covid-19 Impact Analysis

4.11. Global Recession Influence

Continued……

Have Any Query? Ask Our Experts @ https://www.reportsanddata.com/speak-to-analyst-form/3476

About Reports and Data                              

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.